Patent ID: 11965028
Assignee: THERANOVIR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 4:
5. The antibody or antibody fragment of claim 1 comprising
a heavy chain of SEQ ID NO: 13 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 13 and a light chain of SEQ ID NO: 26 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 26,
a heavy chain of SEQ ID NO: 14 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 14 and a light chain of SEQ ID NO: 23 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 23, and
a heavy chain of SEQ ID No: 14 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 14 and a light chain of SEQ ID NO: 26 or a sequence sharing at least 80% of sequence identity with the non-CDR regions of SEQ ID NO: 26.